Roers A, Hiller B, Hornung V. Recognition of endogenous nucleic acids by the innate immune system. Immunity. 2016;44:739–54.
Choi Y, Bowman JW, Jung JU. Autophagy during viral infection – a double-edged sword. Nat Rev Microbiol. 2018;16:341–54.
Tian Y, Wang M-L, Zhao J. Crosstalk between autophagy and type i interferon responses in innate antiviral immunity. Viruses. 2019;11:132.
Chen K, Liu J, Cao X. Regulation of type I interferon signaling in immunity and inflammation: a comprehensive review. J Autoimmun. 2017;83:1–11.
Lei C-Q, Zhong B, Zhang Y, Zhang J, Wang S, Shu H-B. Glycogen synthase kinase 3β regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1. Immunity. 2010;33:878–89.
Liu Q, Gu T, Su L-Y, Jiao L, Qiao X, Xu M, et al. GSNOR facilitates antiviral innate immunity by restricting TBK1 cysteine S-nitrosation. Redox Biol. 2021;47:102172.
Tang J-L, Yang Q, Xu C-H, Zhao H, Liu Y-L, Liu C-Y, et al. Histone deacetylase 3 promotes innate antiviral immunity through deacetylation of TBK1. Protein Cell. 2021;12:261–78.
Li X, Zhang Q, Ding Y, Liu Y, Zhao D, Zhao K, et al. Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity. Nat Immunol. 2016;17:806–15.
Zhao W. Negative regulation of TBK1-mediated antiviral immunity. FEBS Lett. 2013;587:542–8.
Liu J, Qian C, Cao X. Post-translational modification control of innate immunity. Immunity. 2016;45:15–30.
Saul VV, Niedenthal R, Pich A, Weber F, Schmitz ML. SUMO modification of TBK1 at the adaptor-binding C-terminal coiled-coil domain contributes to its antiviral activity. Biochim Biophys Acta. 2015;1853:136–43.
Yan Z, Wu H, Liu H, Zhao G, Zhang H, Zhuang W, et al. The protein arginine methyltransferase PRMT1 promotes TBK1 activation through asymmetric arginine methylation. Cell Rep. 2021;36:109731.
Meng Z, Xu R, Xie L, Wu Y, He Q, Gao P, et al. A20/Nrdp1 interaction alters the inflammatory signaling profile by mediating K48- and K63-linked polyubiquitination of effectors MyD88 and TBK1. J Biol Chem. 2021;297:100811.
Parvatiyar K, Barber GN, Harhaj EW. TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases. J Biol Chem. 2010;285:14999–5009.
Friedman CS, O’Donnell MA, Legarda-Addison D, Ng A, Cárdenas WB, Yount JS, et al. The tumor suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep. 2008;9:930–6.
Xie W, Jin S, Zhang C, Yang S, Wu Y, Zhao Y, et al. Selective autophagy controls the stability of TBK1 via NEDD4 to balance host defense. Cell Death Differ. 2022;29:40–53.
Charoenthongtrakul S, Gao L, Harhaj EW. The NLRP4-DTX4 axis: a key suppressor of TBK1 and innate antiviral signaling. Cell Mol Immunol. 2012;9:431–3.
Hu Z, Zhang Y, Xie Y, Yang J, Tang H, Fan B, et al. The toxoplasma effector GRA4 hijacks Host TBK1 to oppositely regulate anti-T. Gondii immunity and tumor immunotherapy. Adv Sci. 2024;11:e2400952.
Zhang M, Wang L, Zhao X, Zhao K, Meng H, Zhao W, et al. TRAF-interacting protein (TRIP) negatively regulates IFN-β production and antiviral response by promoting proteasomal degradation of TANK-binding kinase 1. J Exp Med. 2012;209:1703–11.
Lin M, Zhao Z, Yang Z, Meng Q, Tan P, Xie W, et al. USP38 inhibits type I interferon signaling by editing TBK1 ubiquitination through NLRP4 signalosome. Mol Cell. 2016;64:267–81.
Hu Z, Xie Y, Lu J, Yang J, Zhang J, Jiang H, et al. VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation. Sci Adv. 2023;9:eadg2339.
Jing F, Zhang J, Zhang H, Li T. Unlocking the multifaceted molecular functions and diverse disease implications of lactylation. Biol Rev Camb Philos Soc. 2025;100:172–89.
Li H, Sun L, Gao P, Hu H. Lactylation in cancer: current understanding and challenges. Cancer Cell. 2024;42:1803–7.
Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575–80.
Li H, Liu C, Li R, Zhou L, Ran Y, Yang Q, et al. AARS1 and AARS2 sense L-lactate to regulate cGAS as global lysine lactyltransferases. Nature. 2024;634:1229–37.
Hu Y, He Z, Li Z, Wang Y, Wu N, Sun H, et al. Lactylation: the novel histone modification influence on gene expression, protein function, and disease. Clin Epigenetics. 2024;16:72.
Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y, et al. Lactate and lactylation in cancer. Signal Transduct Target Ther. 2025;10:38.
Zong Z, Ren J, Yang B, Zhang L, Zhou F. Emerging roles of lysine lactyltransferases and lactylation. Nat Cell Biol. 2025;27:563–74.
Wang S, Lv H, Zhou F. AARS1 and AARS2, the L-lactate sensors and universal lactyltransferases. Sci Bull. 2025;70:1547–9.
Zong Z, Xie F, Wang S, Wu X, Zhang Z, Yang B, et al. Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis. Cell. 2024;187:2375–.e33.
Ju J, Zhang H, Lin M, Yan Z, An L, Cao Z, et al. The alanyl-tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer. J Clin Invest. 2024;134:e174587.
Li X, Zhang C, Mei Y, Zhong W, Fan W, Liu L, et al. Irinotecan alleviates chemoresistance to anthracyclines through the inhibition of AARS1-mediated BLM lactylation and homologous recombination repair. Signal Transduct Target Ther. 2025;10:214.
Lin J, Yin Y, Cao J, Zhang Y, Chen J, Chen R, et al. NUDT21 lactylation reprograms alternative polyadenylation to promote cuproptosis resistance. Cell Discov. 2025;11:52.
Xing Z, Yang T, Li X, Xu H, Hong Y, Shao S, et al. High-glucose-associated YTHDC1 lactylation reduces the sensitivity of bladder cancer to enfortumab vedotin therapy. Cell Rep. 2025;44:115545.
Du R, Gao Y, Yan C, Ren X, Qi S, Liu G, et al. Sirtuin 1/sirtuin 3 are robust lysine delactylases and sirtuin 1-mediated delactylation regulates glycolysis. iScience. 2024;27:110911.
Zu H, Li C, Dai C, Pan Y, Ding C, Sun H, et al. SIRT2 functions as a histone delactylase and inhibits the proliferation and migration of neuroblastoma cells. Cell Discov. 2022;8:54.
Jin J, Bai L, Wang D, Ding W, Cao Z, Yan P, et al. SIRT3-dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth. EMBO Rep. 2023;24:e56052.
Iozzo M, Pardella E, Giannoni E, Chiarugi P. The role of protein lactylation: a kaleidoscopic posttranslational modification in cancer. Mol Cell. 2025;85:1263–79.
Nickel GA, Pederson NJ, Faheem, Yang Z, Bulf J, Diehl KL. Sirtuin 6 is a histone delactylase. J Biol Chem. 2025;301:110795.
Li W, Zhou J, Gu Y, Chen Y, Huang Y, Yang J, et al. Lactylation of RNA m6A demethylase ALKBH5 promotes innate immune response to DNA herpesviruses and mpox virus. Proc Natl Acad Sci USA. 2024;121:e2409132121.
Zou L, Liu Z, Peng L, Wu B, Huang Y, Wen X, et al. Delactylation of H3K9 by Sirtuin6 inhibits MGMT transcription and reverses temozolomide resistance in glioblastoma. Int J Biol Macromol. 2025;327:147332.
Hegazy M, Cohen-Barak E, Koetsier JL, Najor NA, Arvanitis C, Sprecher E, et al. Proximity ligation assay for detecting protein‒protein interactions and protein modifications in cells and tissues in situ. Curr Protoc Cell Biol. 2020;89:e115.
Karaca E, Lewicki J, Hermanson O. Oxygen-dependent acetylation and dimerization of the corepressor CtBP2 in neural stem cells. Exp Cell Res. 2015;332:128–35.
Dai C, Tang Y, Yang H, Zheng J. YTHDC1 lactylation regulates its phase separation to enhance target mRNA stability and promote RCC progression. Mol Cell. 2025;85:2733–.e7.
Lin Z, Long F, Liu J, Kang R, Klionsky DJ, Kroemer G, et al. Metabolic reprogramming promotes apoptosis resistance in acute lymphoblastic leukemia through CASP3 lactylation. Mol Cancer. 2025;24:204.
Gao R, Li Y, Xu Z, Zhang F, Xu J, Hu Y, et al. Mitochondrial pyruvate carrier 1 regulates fatty acid synthase lactylation and mediates treatment of nonalcoholic fatty liver disease. Hepatology. 2023;78:1800–15.
Tian Q, Li J, Wu B, Pang Y, He W, Xiao Q, et al. APP lysine 612 lactylation ameliorates amyloid pathology and memory decline in Alzheimer’s disease. J Clin Invest. 2025;135:e184656.
Yu F, Meng Y, Wang X, Chen J, He J, Yi X, et al. Protein lactylation of citrate synthase promotes the AKI-CKD transition by activating the NLRP3 inflammasome. Cell Rep. 2025;44:116084.
Geng A, Tang H, Huang J, Qian Z, Qin N, Yao Y, et al. The deacetylase SIRT6 promotes the repair of UV-induced DNA damage by targeting DDB2. Nucleic Acids Res. 2020;48:9181–94.
Mao Z, Hine C, Tian X, Van Meter M, Au M, Vaidya A, et al. SIRT6 promotes DNA repair under stress by activating PARP1. Science. 2011;332:1443–6.
Guo Z, Li P, Ge J, Li H. SIRT6 in aging, metabolism, inflammation and cardiovascular diseases. Aging Dis. 2022;13:1787–822.
Liu G, Chen H, Liu H, Zhang W, Zhou J. Emerging roles of SIRT6 in human diseases and its modulators. Med Res Rev. 2021;41:1089–137.
Chang AR, Ferrer CM, Mostoslavsky R. SIRT6, a mammalian deacylase with multitasking abilities. Physiol Rev. 2020;100:145–69.
Hou T, Tian Y, Cao Z, Zhang J, Feng T, Tao W, et al. Cytoplasmic SIRT6-mediated ACSL5 deacetylation impedes nonalcoholic fatty liver disease by facilitating hepatic fatty acid oxidation. Mol Cell. 2022;82:4099–.e9.
Zhao X, Di Q, Yu J, Quan J, Xiao Y, Zhu H, et al. USP19 (ubiquitin specific peptidase 19) promotes TBK1 (TANK-binding kinase 1) degradation via chaperone-mediated autophagy. Autophagy. 2022;18:891–908.
Xie W, Zhang C, Wang Z, Chen H, Gu T, Zhou T, et al. ATG4B antagonizes antiviral immunity by GABARAP-directed autophagic degradation of TBK1. Autophagy. 2023;19:2853–68.
Jiao Y, Zhao P, Xu L-D, Yu J-Q, Cai H-L, Zhang C, et al. Enteric coronavirus nsp2 is a virulence determinant that recruits NBR1 for autophagic targeting of TBK1 to diminish the innate immune response. Autophagy. 2024;20:1762–79.
Romao S, Münz C. LC3-associated phagocytosis. Autophagy. 2014;10:526–8.
Khaminets A, Behl C, Dikic I. Ubiquitin-dependent and independent signals in selective autophagy. Trends Cell Biol. 2016;26:6–16.
Isogai S, Morimoto D, Arita K, Unzai S, Tenno T, Hasegawa J, et al. Crystal structure of the ubiquitin-associated (UBA) domain of p62 and its interaction with ubiquitin. J Biol Chem. 2011;286:31864–74.
Squair DR, Virdee S. A new dawn beyond lysine ubiquitination. Nat Chem Biol. 2022;18:802–11.
Zheng N, Shabek N. Ubiquitin ligases: structure, function, and regulation. Annu Rev Biochem. 2017;86:129–57.
Zheng Q, Hou J, Zhou Y, Yang Y, Xie B, Cao X. Siglec1 suppresses antiviral innate immune response by inducing TBK1 degradation via the ubiquitin ligase TRIM27. Cell Res. 2015;25:1121–36.
Wang C, Chen T, Zhang J, Yang M, Li N, Xu X, et al. The E3 ubiquitin ligase Nrdp1 ‘preferentially’ promotes TLR-mediated production of type I interferon. Nat Immunol. 2009;10:744–52.
Song G, Liu B, Li Z, Wu H, Wang P, Zhao K, et al. E3 ubiquitin ligase RNF128 promotes innate antiviral immunity through K63-linked ubiquitination of TBK1. Nat Immunol. 2016;17:1342–51.
Cui J, Li Y, Zhu L, Liu D, Songyang Z, Wang HY, et al. NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nat Immunol. 2012;13:387–95.
Zhao X, Di Q, Chen J, Ling J, Quan J, Zhao Z, et al. The USP43/RNF2 axis negatively regulates antiviral innate immunity by promoting TBK1 ubiquitination and degradation. Cell Death Differ. 2025;32:1806–19.
Dong B, Ding C, Xiang H, Zheng J, Li X, Xue W, et al. USP7 accelerates FMR1-mediated ferroptosis by facilitating TBK1 ubiquitination and DNMT1 deubiquitination after renal ischemia‒reperfusion injury. Inflamm Res. 2022;71:1519–33.
Cai J, Chen H-Y, Peng S-J, Meng J-L, Wang Y, Zhou Y, et al. USP7-TRIM27 axis negatively modulates antiviral type I IFN signaling. FASEB J. 2018;32:5238–49.
Rao K, Zhang X, Luo Y, Xia Q, Jin Y, He J. Lactylation orchestrates ubiquitin-independent degradation of cGAS and promotes tumor growth. Cell Rep. 2025;44:115441.
Zhang J, Ji H, Liu M, Zheng M, Wen Z, Shen H. Mitochondrial DNA programs lactylation of cGAS to induce IFN responses in patients with systemic lupus erythematosus. J Immunol. 2024;213:795–807.
Venne AS, Kollipara L, Zahedi RP. The next level of complexity: crosstalk of posttranslational modifications. Proteomics. 2014;14:513–24.
Xu H-D, Wang L-N, Wen P-P, Shi S-P, Qiu J-D. Site-specific systematic analysis of lysine modification crosstalk. Proteomics. 2018;18:e1700292.
Wang H, Hu D, Cheng Y, Gao Q, Liu K, Mani NL, et al. Succinate drives gut inflammation by promoting FOXP3 degradation through a molecular switch. Nat Immunol. 2025;26:866–80.
Wu XY, Zhang ZW, Chen SN, Pang AN, Peng XY, Li N, et al. SIRT6 positively regulates antiviral response in a bony fish, the Chinese perch Siniperca chuatsi. Fish Shellfish Immunol. 2024;150:109662.
Yuan S, Liao G, Zhang M, Zhu Y, Xiao W, Wang K, et al. Multiomics interrogation into HBV (Hepatitis B virus)-host interaction reveals novel coding potential in human genome, and identifies canonical and noncanonical proteins as host restriction factors against HBV. Cell Discov. 2021;7:105.
Hu M, Armstrong N, Seto E, Li W, Zhu F, Wang PC, et al. Sirtuin 6 attenuates kaposi’s sarcoma-associated herpesvirus reactivation by suppressing Ori-Lyt activity and expression of RTA. J Virol. 2019;93:e02200-18.
